Review





Similar Products

99
NSJ Bioreagents il-6 antibody
Il 6 Antibody, supplied by NSJ Bioreagents, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/il+6/IL-6+Antibody/custom%40v2346%4042774904
Average 99 stars, based on 1 article reviews
il-6 antibody - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

94
Sino Biological mouse il 6 elisa kit
NANP alters the immunomodulatory properties of MSCs‐exo. (A) Strategy for in vitro MSCs‐exo‐mediated inhibition of OT‐I cell proliferation. (B) Representative histograms showing the proliferation of eFluor670‐labeled OT‐I cells in vitro. Statistical analysis of OT‐I cell‐associated MFI is shown ( n = 3). (C, D) Representative histograms illustrating CD86 (C) and MHC‐II (D) expression in BMDC after Poly(I:C) stimulation with or without different MSCs‐exo. Statistical analysis of mean fluorescence intensity (MFI) is shown ( n = 3). (E, F) RAW264.7 cells were pretreated with LPS (100 ng mL −1 ) and IFN‐γ (10 ng mL −1 ) for 2 h, and then cultured with 20 µg mL −1 exosomes from MSCs or NAD + ‐loaded MSCs for another 12 h. The mRNA expressions of Tnf‐a, <t>Il‐6,</t> Nos2 , and Il‐10 genes were detected by using qRT‐PCR assay (E) ( n = 3), and the proportions of iNOS + F4/80 + and CD206 + F4/80 + cells were detected by flow cytometry (F) (n = 3). (G) Relative Pd‐l1 mRNA levels in MSCs treated with IT, 25 µM NANP, or a combination of both for 24 h (bottom panel), and Western blot analysis of PD‐L1 in exosomes derived from MSCs treated with 25 µM NANP or not (top panel). Data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.
Mouse Il 6 Elisa Kit, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/il+6/Mouse+IL6ST+%2F+gp130+%2F+CD130+ELISA+Pair+Set/pmc13752232-299-7-14
Average 94 stars, based on 1 article reviews
mouse il 6 elisa kit - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

96
Elabscience Biotechnology il 6
NANP alters the immunomodulatory properties of MSCs‐exo. (A) Strategy for in vitro MSCs‐exo‐mediated inhibition of OT‐I cell proliferation. (B) Representative histograms showing the proliferation of eFluor670‐labeled OT‐I cells in vitro. Statistical analysis of OT‐I cell‐associated MFI is shown ( n = 3). (C, D) Representative histograms illustrating CD86 (C) and MHC‐II (D) expression in BMDC after Poly(I:C) stimulation with or without different MSCs‐exo. Statistical analysis of mean fluorescence intensity (MFI) is shown ( n = 3). (E, F) RAW264.7 cells were pretreated with LPS (100 ng mL −1 ) and IFN‐γ (10 ng mL −1 ) for 2 h, and then cultured with 20 µg mL −1 exosomes from MSCs or NAD + ‐loaded MSCs for another 12 h. The mRNA expressions of Tnf‐a, <t>Il‐6,</t> Nos2 , and Il‐10 genes were detected by using qRT‐PCR assay (E) ( n = 3), and the proportions of iNOS + F4/80 + and CD206 + F4/80 + cells were detected by flow cytometry (F) (n = 3). (G) Relative Pd‐l1 mRNA levels in MSCs treated with IT, 25 µM NANP, or a combination of both for 24 h (bottom panel), and Western blot analysis of PD‐L1 in exosomes derived from MSCs treated with 25 µM NANP or not (top panel). Data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.
Il 6, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/il+6/Human+IL-6+(Interleukin+6)+ELISA+Kit/pmc13748043-204-3-18
Average 96 stars, based on 1 article reviews
il 6 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
R&D Systems il 6
NANP alters the immunomodulatory properties of MSCs‐exo. (A) Strategy for in vitro MSCs‐exo‐mediated inhibition of OT‐I cell proliferation. (B) Representative histograms showing the proliferation of eFluor670‐labeled OT‐I cells in vitro. Statistical analysis of OT‐I cell‐associated MFI is shown ( n = 3). (C, D) Representative histograms illustrating CD86 (C) and MHC‐II (D) expression in BMDC after Poly(I:C) stimulation with or without different MSCs‐exo. Statistical analysis of mean fluorescence intensity (MFI) is shown ( n = 3). (E, F) RAW264.7 cells were pretreated with LPS (100 ng mL −1 ) and IFN‐γ (10 ng mL −1 ) for 2 h, and then cultured with 20 µg mL −1 exosomes from MSCs or NAD + ‐loaded MSCs for another 12 h. The mRNA expressions of Tnf‐a, <t>Il‐6,</t> Nos2 , and Il‐10 genes were detected by using qRT‐PCR assay (E) ( n = 3), and the proportions of iNOS + F4/80 + and CD206 + F4/80 + cells were detected by flow cytometry (F) (n = 3). (G) Relative Pd‐l1 mRNA levels in MSCs treated with IT, 25 µM NANP, or a combination of both for 24 h (bottom panel), and Western blot analysis of PD‐L1 in exosomes derived from MSCs treated with 25 µM NANP or not (top panel). Data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.
Il 6, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/il+6/Human+IL-1+beta%2FIL-1F2+DuoSet+ELISA/pmc13748623-589-1-16
Average 96 stars, based on 1 article reviews
il 6 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
R&D Systems human interleukin 6
NANP alters the immunomodulatory properties of MSCs‐exo. (A) Strategy for in vitro MSCs‐exo‐mediated inhibition of OT‐I cell proliferation. (B) Representative histograms showing the proliferation of eFluor670‐labeled OT‐I cells in vitro. Statistical analysis of OT‐I cell‐associated MFI is shown ( n = 3). (C, D) Representative histograms illustrating CD86 (C) and MHC‐II (D) expression in BMDC after Poly(I:C) stimulation with or without different MSCs‐exo. Statistical analysis of mean fluorescence intensity (MFI) is shown ( n = 3). (E, F) RAW264.7 cells were pretreated with LPS (100 ng mL −1 ) and IFN‐γ (10 ng mL −1 ) for 2 h, and then cultured with 20 µg mL −1 exosomes from MSCs or NAD + ‐loaded MSCs for another 12 h. The mRNA expressions of Tnf‐a, <t>Il‐6,</t> Nos2 , and Il‐10 genes were detected by using qRT‐PCR assay (E) ( n = 3), and the proportions of iNOS + F4/80 + and CD206 + F4/80 + cells were detected by flow cytometry (F) (n = 3). (G) Relative Pd‐l1 mRNA levels in MSCs treated with IT, 25 µM NANP, or a combination of both for 24 h (bottom panel), and Western blot analysis of PD‐L1 in exosomes derived from MSCs treated with 25 µM NANP or not (top panel). Data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.
Human Interleukin 6, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/il+6/Recombinant+Human+IL-6+Protein/pm42994959-54-25-27
Average 96 stars, based on 1 article reviews
human interleukin 6 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

93
Cusabio interleukin il 6
A104R inhibits antiviral gene transcription and cGAS-STING pathway signaling. A The 3D4/21 cells were transfected with Flag-tagged A104R or the control vector and infected with ADV-GFP at a MOI of 1. At the indicated timepoints, A104R expression and the levels of total and phosphorylated TBK1, IRF3, IκBα, p65, and STAT1 were detected by immunoblotting. The numerical values below the panels represent the relative intensity normalized to the β-actin (internal control). B The 3D4/21 cells were transfected with Flag-tagged A104R or the Flag control vector. At 24 hpt, cells were infected with ADV-GFP at a multiplicity of infection (MOI) of 1.0. At the indicated timepoints, total RNA was extracted, and the mRNA levels of the indicated genes were measured by RT-qPCR. The numerical values below the anti-Strep and -Flag panels in the GST PD represent the relative intensity of the Strep-IRF3 and Flag-A104R signals, normalized to the corresponding GST-IRF3 bait in the same GST PD. C PK-15 cells were transfected with Flag-tagged A104R or the control vector and infected with ADV-GFP at an MOI of 1.0 At the indicated timepoints, A104R expression and the levels of total and phosphorylated TBK1, IRF3, IκBα, p65, and STAT1 were analyzed by immunoblotting. The numerical values below the panels represent the relative intensity normalized to the β-actin (internal control). D PK-15 cells were transfected with Flag-tagged A104R or the control vector and infected with ADV-GFP at an MOI of 1.0 at 24 hpt. At the indicated timepoints, total RNA was extracted, and the mRNA levels of the indicated genes were measured by RT-qPCR. Data are representative of three independent experiments. Values represent the mean ± SD of three biological replicates from a representative experiment. Unpaired Student’s t -test: * P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001, or **** P ≤ 0.0001. ns: not significant.
Interleukin Il 6, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/il+6/Pig+Interleukin+6%2CIL-6+ELISA+Kit/pmc13744117-97-5-7
Average 93 stars, based on 1 article reviews
interleukin il 6 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

96
R&D Systems human il 6 quantikine elisa kit
Effects of FMT on BMD and longitudinal serum markers in patients with DOP. Note: (A) Experimental schematic showing grouping and study design for diabetic patients receiving FMT treatment, diabetic patients without FMT, and healthy controls; (B) Dual-energy X-ray image; (C-D) longitudinal BMD changes at the lumbar spine and femoral neck; (E-G) longitudinal serum inflammatory markers, including hs-CRP, <t>IL-6,</t> and TNF-α; (H-K) longitudinal bone-metabolism markers, including CTX, TRAP, OC, and ALP. Patients were followed for 24 weeks (6 months), and peripheral blood samples were collected every 4 weeks for serum marker detection. Lines indicate measured values at each time point, and shaded bands indicate the upper and lower ranges. CON n = 10, DOP n = 10, DOP+FMT n = 10. Statistical analysis was performed usingANOVA followed by Šídák's multiple-comparisons test. * p < 0.05, ** p < 0.01, *** p < 0.001.
Human Il 6 Quantikine Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/il+6/Human+IL-6+Quantikine+ELISA+Kit/pmc13757687-52-19-25
Average 96 stars, based on 1 article reviews
human il 6 quantikine elisa kit - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

97
R&D Systems mouse il 6 quantikine elisa kit
Effects of FMT on BMD and longitudinal serum markers in patients with DOP. Note: (A) Experimental schematic showing grouping and study design for diabetic patients receiving FMT treatment, diabetic patients without FMT, and healthy controls; (B) Dual-energy X-ray image; (C-D) longitudinal BMD changes at the lumbar spine and femoral neck; (E-G) longitudinal serum inflammatory markers, including hs-CRP, <t>IL-6,</t> and TNF-α; (H-K) longitudinal bone-metabolism markers, including CTX, TRAP, OC, and ALP. Patients were followed for 24 weeks (6 months), and peripheral blood samples were collected every 4 weeks for serum marker detection. Lines indicate measured values at each time point, and shaded bands indicate the upper and lower ranges. CON n = 10, DOP n = 10, DOP+FMT n = 10. Statistical analysis was performed usingANOVA followed by Šídák's multiple-comparisons test. * p < 0.05, ** p < 0.01, *** p < 0.001.
Mouse Il 6 Quantikine Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/il+6/Mouse+IL-6+Quantikine+ELISA+Kit/pmc13757687-57-26-32
Average 97 stars, based on 1 article reviews
mouse il 6 quantikine elisa kit - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc anti il 6
Effects of FMT on BMD and longitudinal serum markers in patients with DOP. Note: (A) Experimental schematic showing grouping and study design for diabetic patients receiving FMT treatment, diabetic patients without FMT, and healthy controls; (B) Dual-energy X-ray image; (C-D) longitudinal BMD changes at the lumbar spine and femoral neck; (E-G) longitudinal serum inflammatory markers, including hs-CRP, <t>IL-6,</t> and TNF-α; (H-K) longitudinal bone-metabolism markers, including CTX, TRAP, OC, and ALP. Patients were followed for 24 weeks (6 months), and peripheral blood samples were collected every 4 weeks for serum marker detection. Lines indicate measured values at each time point, and shaded bands indicate the upper and lower ranges. CON n = 10, DOP n = 10, DOP+FMT n = 10. Statistical analysis was performed usingANOVA followed by Šídák's multiple-comparisons test. * p < 0.05, ** p < 0.01, *** p < 0.001.
Anti Il 6, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/il+6/IL-6+Rabbit+mAb/pm42988019-116-24-26
Average 96 stars, based on 1 article reviews
anti il 6 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

Image Search Results


NANP alters the immunomodulatory properties of MSCs‐exo. (A) Strategy for in vitro MSCs‐exo‐mediated inhibition of OT‐I cell proliferation. (B) Representative histograms showing the proliferation of eFluor670‐labeled OT‐I cells in vitro. Statistical analysis of OT‐I cell‐associated MFI is shown ( n = 3). (C, D) Representative histograms illustrating CD86 (C) and MHC‐II (D) expression in BMDC after Poly(I:C) stimulation with or without different MSCs‐exo. Statistical analysis of mean fluorescence intensity (MFI) is shown ( n = 3). (E, F) RAW264.7 cells were pretreated with LPS (100 ng mL −1 ) and IFN‐γ (10 ng mL −1 ) for 2 h, and then cultured with 20 µg mL −1 exosomes from MSCs or NAD + ‐loaded MSCs for another 12 h. The mRNA expressions of Tnf‐a, Il‐6, Nos2 , and Il‐10 genes were detected by using qRT‐PCR assay (E) ( n = 3), and the proportions of iNOS + F4/80 + and CD206 + F4/80 + cells were detected by flow cytometry (F) (n = 3). (G) Relative Pd‐l1 mRNA levels in MSCs treated with IT, 25 µM NANP, or a combination of both for 24 h (bottom panel), and Western blot analysis of PD‐L1 in exosomes derived from MSCs treated with 25 µM NANP or not (top panel). Data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.

Journal: Exploration

Article Title: Metabolic Nanomedicine Reprograms Mesenchymal Stem Cells for Durable Exosome‐Mediated Immunomodulation

doi: 10.1002/exp2.70249

Figure Lengend Snippet: NANP alters the immunomodulatory properties of MSCs‐exo. (A) Strategy for in vitro MSCs‐exo‐mediated inhibition of OT‐I cell proliferation. (B) Representative histograms showing the proliferation of eFluor670‐labeled OT‐I cells in vitro. Statistical analysis of OT‐I cell‐associated MFI is shown ( n = 3). (C, D) Representative histograms illustrating CD86 (C) and MHC‐II (D) expression in BMDC after Poly(I:C) stimulation with or without different MSCs‐exo. Statistical analysis of mean fluorescence intensity (MFI) is shown ( n = 3). (E, F) RAW264.7 cells were pretreated with LPS (100 ng mL −1 ) and IFN‐γ (10 ng mL −1 ) for 2 h, and then cultured with 20 µg mL −1 exosomes from MSCs or NAD + ‐loaded MSCs for another 12 h. The mRNA expressions of Tnf‐a, Il‐6, Nos2 , and Il‐10 genes were detected by using qRT‐PCR assay (E) ( n = 3), and the proportions of iNOS + F4/80 + and CD206 + F4/80 + cells were detected by flow cytometry (F) (n = 3). (G) Relative Pd‐l1 mRNA levels in MSCs treated with IT, 25 µM NANP, or a combination of both for 24 h (bottom panel), and Western blot analysis of PD‐L1 in exosomes derived from MSCs treated with 25 µM NANP or not (top panel). Data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.

Article Snippet: Serum IL‐6 levels were measured using a mouse IL‐6 ELISA kit ( SEK50135 , Sino Biological Inc.).

Techniques: In Vitro, Inhibition, Labeling, Analysis, Expressing, Fluorescence, Cell Culture, Exosomes, Quantitative RT-PCR, Flow Cytometry, Western Blot, Derivative Assay

NANP modulates the miRNA content in exosomes through the upregulation of SMPD3. (A) Volcano plot showing the differential expression analysis of miRNAs between MSCs‐exo and NAD + ‐loaded MSCs‐exo. (B) GO analysis of significantly enriched genes in NAD + ‐loaded MSCs‐exo compared to MSCs‐exo. (C) Heatmap illustrating the upregulation of miRNAs in NAD + ‐loaded MSCs‐exo compared to MSCs‐exo. (D) qRT‐PCR analysis of miR‐30a‐5p, miR‐146a‐5p, and miR‐146b‐5p expression in exosomes from MSCs treated with or without NANP. (E) RAW264.7 cells were pretreated with LPS (100 ng mL −1 ) and IFN‐γ (10 ng mL −1 ) for 2 h, followed by transfection with siRNA‐ctrl or a combination of miR‐30a‐5p, miR‐146a‐5p, and miR‐146b‐5p mimics (miR‐30a/146a/146b) for an additional 24 h. The mRNA expressions of the Tnf‐a , Il‐6 , Nos2 , and Il‐10 genes were detected using qRT‐PCR ( n = 3). (F) The mRNA expressions of Hnrnpa2b1 , Smpd3 , Anxa2 , Ybx1 , and Syncrip of MSCs with or without 25 µM NANP treatment for 48 h ( n = 3). (G) Protein levels of SMPD3 and YBX1 in MSCs with or without NANP (25 µM, 48 h) treatment. (H) Western blot and qRT‐PCR showing that MSCs with shRNA‐mediated SMPD3 knockdown (MSCs‐sh‐Smpd3) fail to respond to NANP‐induced SMPD3 upregulation. (I) Western blot analysis of the exosomal markers TSG101 and CD81 detected in exosomes derived from MSCs‐sh‐Ctrl and MSCs‐sh‐Smpd3 cells. (J) The expression of miR‐30a‐5p, miR‐146a‐5p, and miR‐146b‐5p in exosomes derived from MSCs‐sh‐Ctrl and MSCs‐sh‐Smpd3 in the presence or absence of NANP, measured by qRT‐PCR ( n = 3). Data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.

Journal: Exploration

Article Title: Metabolic Nanomedicine Reprograms Mesenchymal Stem Cells for Durable Exosome‐Mediated Immunomodulation

doi: 10.1002/exp2.70249

Figure Lengend Snippet: NANP modulates the miRNA content in exosomes through the upregulation of SMPD3. (A) Volcano plot showing the differential expression analysis of miRNAs between MSCs‐exo and NAD + ‐loaded MSCs‐exo. (B) GO analysis of significantly enriched genes in NAD + ‐loaded MSCs‐exo compared to MSCs‐exo. (C) Heatmap illustrating the upregulation of miRNAs in NAD + ‐loaded MSCs‐exo compared to MSCs‐exo. (D) qRT‐PCR analysis of miR‐30a‐5p, miR‐146a‐5p, and miR‐146b‐5p expression in exosomes from MSCs treated with or without NANP. (E) RAW264.7 cells were pretreated with LPS (100 ng mL −1 ) and IFN‐γ (10 ng mL −1 ) for 2 h, followed by transfection with siRNA‐ctrl or a combination of miR‐30a‐5p, miR‐146a‐5p, and miR‐146b‐5p mimics (miR‐30a/146a/146b) for an additional 24 h. The mRNA expressions of the Tnf‐a , Il‐6 , Nos2 , and Il‐10 genes were detected using qRT‐PCR ( n = 3). (F) The mRNA expressions of Hnrnpa2b1 , Smpd3 , Anxa2 , Ybx1 , and Syncrip of MSCs with or without 25 µM NANP treatment for 48 h ( n = 3). (G) Protein levels of SMPD3 and YBX1 in MSCs with or without NANP (25 µM, 48 h) treatment. (H) Western blot and qRT‐PCR showing that MSCs with shRNA‐mediated SMPD3 knockdown (MSCs‐sh‐Smpd3) fail to respond to NANP‐induced SMPD3 upregulation. (I) Western blot analysis of the exosomal markers TSG101 and CD81 detected in exosomes derived from MSCs‐sh‐Ctrl and MSCs‐sh‐Smpd3 cells. (J) The expression of miR‐30a‐5p, miR‐146a‐5p, and miR‐146b‐5p in exosomes derived from MSCs‐sh‐Ctrl and MSCs‐sh‐Smpd3 in the presence or absence of NANP, measured by qRT‐PCR ( n = 3). Data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.

Article Snippet: Serum IL‐6 levels were measured using a mouse IL‐6 ELISA kit ( SEK50135 , Sino Biological Inc.).

Techniques: Exosomes, Quantitative Proteomics, Analysis, Quantitative RT-PCR, Expressing, Transfection, Western Blot, shRNA, Knockdown, Derivative Assay, Cell Surface Receptor Assay, Gene Expression

A104R inhibits antiviral gene transcription and cGAS-STING pathway signaling. A The 3D4/21 cells were transfected with Flag-tagged A104R or the control vector and infected with ADV-GFP at a MOI of 1. At the indicated timepoints, A104R expression and the levels of total and phosphorylated TBK1, IRF3, IκBα, p65, and STAT1 were detected by immunoblotting. The numerical values below the panels represent the relative intensity normalized to the β-actin (internal control). B The 3D4/21 cells were transfected with Flag-tagged A104R or the Flag control vector. At 24 hpt, cells were infected with ADV-GFP at a multiplicity of infection (MOI) of 1.0. At the indicated timepoints, total RNA was extracted, and the mRNA levels of the indicated genes were measured by RT-qPCR. The numerical values below the anti-Strep and -Flag panels in the GST PD represent the relative intensity of the Strep-IRF3 and Flag-A104R signals, normalized to the corresponding GST-IRF3 bait in the same GST PD. C PK-15 cells were transfected with Flag-tagged A104R or the control vector and infected with ADV-GFP at an MOI of 1.0 At the indicated timepoints, A104R expression and the levels of total and phosphorylated TBK1, IRF3, IκBα, p65, and STAT1 were analyzed by immunoblotting. The numerical values below the panels represent the relative intensity normalized to the β-actin (internal control). D PK-15 cells were transfected with Flag-tagged A104R or the control vector and infected with ADV-GFP at an MOI of 1.0 at 24 hpt. At the indicated timepoints, total RNA was extracted, and the mRNA levels of the indicated genes were measured by RT-qPCR. Data are representative of three independent experiments. Values represent the mean ± SD of three biological replicates from a representative experiment. Unpaired Student’s t -test: * P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001, or **** P ≤ 0.0001. ns: not significant.

Journal: Veterinary Research

Article Title: African swine fever virus histone-like protein A104R subverts host antiviral defenses by suppressing the nuclear translocation of IRF3 and STAT1

doi: 10.1186/s13567-026-01874-z

Figure Lengend Snippet: A104R inhibits antiviral gene transcription and cGAS-STING pathway signaling. A The 3D4/21 cells were transfected with Flag-tagged A104R or the control vector and infected with ADV-GFP at a MOI of 1. At the indicated timepoints, A104R expression and the levels of total and phosphorylated TBK1, IRF3, IκBα, p65, and STAT1 were detected by immunoblotting. The numerical values below the panels represent the relative intensity normalized to the β-actin (internal control). B The 3D4/21 cells were transfected with Flag-tagged A104R or the Flag control vector. At 24 hpt, cells were infected with ADV-GFP at a multiplicity of infection (MOI) of 1.0. At the indicated timepoints, total RNA was extracted, and the mRNA levels of the indicated genes were measured by RT-qPCR. The numerical values below the anti-Strep and -Flag panels in the GST PD represent the relative intensity of the Strep-IRF3 and Flag-A104R signals, normalized to the corresponding GST-IRF3 bait in the same GST PD. C PK-15 cells were transfected with Flag-tagged A104R or the control vector and infected with ADV-GFP at an MOI of 1.0 At the indicated timepoints, A104R expression and the levels of total and phosphorylated TBK1, IRF3, IκBα, p65, and STAT1 were analyzed by immunoblotting. The numerical values below the panels represent the relative intensity normalized to the β-actin (internal control). D PK-15 cells were transfected with Flag-tagged A104R or the control vector and infected with ADV-GFP at an MOI of 1.0 at 24 hpt. At the indicated timepoints, total RNA was extracted, and the mRNA levels of the indicated genes were measured by RT-qPCR. Data are representative of three independent experiments. Values represent the mean ± SD of three biological replicates from a representative experiment. Unpaired Student’s t -test: * P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001, or **** P ≤ 0.0001. ns: not significant.

Article Snippet: Porcine IFN-β (CUSABIO, CSB-#E09890p) and interleukin (IL)-6 (CUSABIO, CSB- #E06786p), human IL-6 (BD OptEIA, #5,552,220), and human IFN-β (CUSABIO, #CSB-E09889h) were used for analysis according to the manufacturer’s protocols.

Techniques: Transfection, Control, Plasmid Preparation, Infection, Expressing, Western Blot, Quantitative RT-PCR

A104R negatively regulates antiviral immune responses in stable 3D4/21 cells. A–C Stable 3D4/21 cells expressing Flag-A104R or the control vector were infected with ADV-GFP, HSV-GFP, or VACV-GFP, respectively, at a multiplicity of infection (MOI) of 1.0. At 12 and 24 h post-infection (hpi), fluorescence intensity levels were quantified, and GFP fluorescence images were captured at 24 hpi. Standard plaque assays were performed in A549 or Vero cells for viral titer determination. D–F Porcine IFN-β and IL-6 concentrations in culture supernatants collected at 12 and 24 hpi were measured by ELISA. Data are representative of three independent experiments. Values represent the mean ± SD of three biological replicates from a representative experiment. Unpaired Student’s t -test: * P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001, or **** P ≤ 0.0001. Scale bar indicates 50 μm.

Journal: Veterinary Research

Article Title: African swine fever virus histone-like protein A104R subverts host antiviral defenses by suppressing the nuclear translocation of IRF3 and STAT1

doi: 10.1186/s13567-026-01874-z

Figure Lengend Snippet: A104R negatively regulates antiviral immune responses in stable 3D4/21 cells. A–C Stable 3D4/21 cells expressing Flag-A104R or the control vector were infected with ADV-GFP, HSV-GFP, or VACV-GFP, respectively, at a multiplicity of infection (MOI) of 1.0. At 12 and 24 h post-infection (hpi), fluorescence intensity levels were quantified, and GFP fluorescence images were captured at 24 hpi. Standard plaque assays were performed in A549 or Vero cells for viral titer determination. D–F Porcine IFN-β and IL-6 concentrations in culture supernatants collected at 12 and 24 hpi were measured by ELISA. Data are representative of three independent experiments. Values represent the mean ± SD of three biological replicates from a representative experiment. Unpaired Student’s t -test: * P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001, or **** P ≤ 0.0001. Scale bar indicates 50 μm.

Article Snippet: Porcine IFN-β (CUSABIO, CSB-#E09890p) and interleukin (IL)-6 (CUSABIO, CSB- #E06786p), human IL-6 (BD OptEIA, #5,552,220), and human IFN-β (CUSABIO, #CSB-E09889h) were used for analysis according to the manufacturer’s protocols.

Techniques: Expressing, Control, Plasmid Preparation, Infection, Fluorescence, Titer Analysis, Enzyme-linked Immunosorbent Assay

Effects of FMT on BMD and longitudinal serum markers in patients with DOP. Note: (A) Experimental schematic showing grouping and study design for diabetic patients receiving FMT treatment, diabetic patients without FMT, and healthy controls; (B) Dual-energy X-ray image; (C-D) longitudinal BMD changes at the lumbar spine and femoral neck; (E-G) longitudinal serum inflammatory markers, including hs-CRP, IL-6, and TNF-α; (H-K) longitudinal bone-metabolism markers, including CTX, TRAP, OC, and ALP. Patients were followed for 24 weeks (6 months), and peripheral blood samples were collected every 4 weeks for serum marker detection. Lines indicate measured values at each time point, and shaded bands indicate the upper and lower ranges. CON n = 10, DOP n = 10, DOP+FMT n = 10. Statistical analysis was performed usingANOVA followed by Šídák's multiple-comparisons test. * p < 0.05, ** p < 0.01, *** p < 0.001.

Journal: Gut Microbes

Article Title: Lactylated MOESIN links gut metabolism to TGF-β–driven immune remodeling and bone protection in diabetic osteoporosis

doi: 10.1080/19490976.2026.2757330

Figure Lengend Snippet: Effects of FMT on BMD and longitudinal serum markers in patients with DOP. Note: (A) Experimental schematic showing grouping and study design for diabetic patients receiving FMT treatment, diabetic patients without FMT, and healthy controls; (B) Dual-energy X-ray image; (C-D) longitudinal BMD changes at the lumbar spine and femoral neck; (E-G) longitudinal serum inflammatory markers, including hs-CRP, IL-6, and TNF-α; (H-K) longitudinal bone-metabolism markers, including CTX, TRAP, OC, and ALP. Patients were followed for 24 weeks (6 months), and peripheral blood samples were collected every 4 weeks for serum marker detection. Lines indicate measured values at each time point, and shaded bands indicate the upper and lower ranges. CON n = 10, DOP n = 10, DOP+FMT n = 10. Statistical analysis was performed usingANOVA followed by Šídák's multiple-comparisons test. * p < 0.05, ** p < 0.01, *** p < 0.001.

Article Snippet: CRP levels were assessed using the Human CRP ELISA Kit (ab260058, Abcam, UK); IL-6 levels were measured using the Human IL-6 Quantikine ELISA Kit (D6050, R&D Systems, USA); and TNF- α levels were measured using the Human TNF-alpha Quantikine ELISA Kit (DTA00D, R&D Systems, USA).

Techniques: Blood/Plasma/Serum Samples, Marker, Analysis, Fecal Microbiota Transplantation

FMT improves DOP in mice by regulating the TGF- β signaling pathway through L-MOESIN. Note: (A-G) Micro-CT analysis of BMD and trabecular architecture across the Control, DOP, DOP+ L. agilis , DOP+FMT, DOP+FMT+L-MOESIN Ab, and DOP+FMT− L. agilis groups; L. agilis denotes the donor-derived ASV_4100-matched Ligilactobacillus agilis isolate, and DOP+FMT− L. agilis denotes strain-matched phage-mediated depletion of L. agilis . Scale bar = 1 mm; (H-J) serum analysis of inflammatory cytokines (CRP, IL-6, TNF-alpha); (K) H&E staining of distal femoral cancellous bone (scale bar = 50 μm); (L) Masson staining (scale bar = 50 μm); (M) TRAP staining (scale bar = 50 μm); (N) Western blot analysis of OCN, Runx2, Cathepsin K, and RANK; (O-R) densitometric quantification. Data are presented as mean ± SD, n = 6 mice per group. Statistical analysis was performed using ANOVA followed by Šídák's multiple-comparisons test for panels B-J and Tukey's multiple-comparisons test for panels O-R. ** p < 0.01, *** p < 0.001, **** p < 0.0001.

Journal: Gut Microbes

Article Title: Lactylated MOESIN links gut metabolism to TGF-β–driven immune remodeling and bone protection in diabetic osteoporosis

doi: 10.1080/19490976.2026.2757330

Figure Lengend Snippet: FMT improves DOP in mice by regulating the TGF- β signaling pathway through L-MOESIN. Note: (A-G) Micro-CT analysis of BMD and trabecular architecture across the Control, DOP, DOP+ L. agilis , DOP+FMT, DOP+FMT+L-MOESIN Ab, and DOP+FMT− L. agilis groups; L. agilis denotes the donor-derived ASV_4100-matched Ligilactobacillus agilis isolate, and DOP+FMT− L. agilis denotes strain-matched phage-mediated depletion of L. agilis . Scale bar = 1 mm; (H-J) serum analysis of inflammatory cytokines (CRP, IL-6, TNF-alpha); (K) H&E staining of distal femoral cancellous bone (scale bar = 50 μm); (L) Masson staining (scale bar = 50 μm); (M) TRAP staining (scale bar = 50 μm); (N) Western blot analysis of OCN, Runx2, Cathepsin K, and RANK; (O-R) densitometric quantification. Data are presented as mean ± SD, n = 6 mice per group. Statistical analysis was performed using ANOVA followed by Šídák's multiple-comparisons test for panels B-J and Tukey's multiple-comparisons test for panels O-R. ** p < 0.01, *** p < 0.001, **** p < 0.0001.

Article Snippet: CRP levels were assessed using the Human CRP ELISA Kit (ab260058, Abcam, UK); IL-6 levels were measured using the Human IL-6 Quantikine ELISA Kit (D6050, R&D Systems, USA); and TNF- α levels were measured using the Human TNF-alpha Quantikine ELISA Kit (DTA00D, R&D Systems, USA).

Techniques: Micro-CT, Analysis, Control, Derivative Assay, Staining, Masson's Trichrome Staining, TRAP Staining, Western Blot

Effects of FMT on BMD and longitudinal serum markers in patients with DOP. Note: (A) Experimental schematic showing grouping and study design for diabetic patients receiving FMT treatment, diabetic patients without FMT, and healthy controls; (B) Dual-energy X-ray image; (C-D) longitudinal BMD changes at the lumbar spine and femoral neck; (E-G) longitudinal serum inflammatory markers, including hs-CRP, IL-6, and TNF-α; (H-K) longitudinal bone-metabolism markers, including CTX, TRAP, OC, and ALP. Patients were followed for 24 weeks (6 months), and peripheral blood samples were collected every 4 weeks for serum marker detection. Lines indicate measured values at each time point, and shaded bands indicate the upper and lower ranges. CON n = 10, DOP n = 10, DOP+FMT n = 10. Statistical analysis was performed usingANOVA followed by Šídák's multiple-comparisons test. * p < 0.05, ** p < 0.01, *** p < 0.001.

Journal: Gut Microbes

Article Title: Lactylated MOESIN links gut metabolism to TGF-β–driven immune remodeling and bone protection in diabetic osteoporosis

doi: 10.1080/19490976.2026.2757330

Figure Lengend Snippet: Effects of FMT on BMD and longitudinal serum markers in patients with DOP. Note: (A) Experimental schematic showing grouping and study design for diabetic patients receiving FMT treatment, diabetic patients without FMT, and healthy controls; (B) Dual-energy X-ray image; (C-D) longitudinal BMD changes at the lumbar spine and femoral neck; (E-G) longitudinal serum inflammatory markers, including hs-CRP, IL-6, and TNF-α; (H-K) longitudinal bone-metabolism markers, including CTX, TRAP, OC, and ALP. Patients were followed for 24 weeks (6 months), and peripheral blood samples were collected every 4 weeks for serum marker detection. Lines indicate measured values at each time point, and shaded bands indicate the upper and lower ranges. CON n = 10, DOP n = 10, DOP+FMT n = 10. Statistical analysis was performed usingANOVA followed by Šídák's multiple-comparisons test. * p < 0.05, ** p < 0.01, *** p < 0.001.

Article Snippet: ELISA determined serum levels of CRP, IL-6, and TNF- α . CRP was measured using the Mouse CRP ELISA Kit (ab222511, Abcam, UK); IL-6 using the Mouse IL-6 Quantikine ELISA Kit (M6000B, R&D Systems, USA); and TNF- α using the Mouse TNF-alpha ELISA Kit (ab208348, Abcam, UK).

Techniques: Blood/Plasma/Serum Samples, Marker, Analysis, Fecal Microbiota Transplantation

FMT improves DOP in mice by regulating the TGF- β signaling pathway through L-MOESIN. Note: (A-G) Micro-CT analysis of BMD and trabecular architecture across the Control, DOP, DOP+ L. agilis , DOP+FMT, DOP+FMT+L-MOESIN Ab, and DOP+FMT− L. agilis groups; L. agilis denotes the donor-derived ASV_4100-matched Ligilactobacillus agilis isolate, and DOP+FMT− L. agilis denotes strain-matched phage-mediated depletion of L. agilis . Scale bar = 1 mm; (H-J) serum analysis of inflammatory cytokines (CRP, IL-6, TNF-alpha); (K) H&E staining of distal femoral cancellous bone (scale bar = 50 μm); (L) Masson staining (scale bar = 50 μm); (M) TRAP staining (scale bar = 50 μm); (N) Western blot analysis of OCN, Runx2, Cathepsin K, and RANK; (O-R) densitometric quantification. Data are presented as mean ± SD, n = 6 mice per group. Statistical analysis was performed using ANOVA followed by Šídák's multiple-comparisons test for panels B-J and Tukey's multiple-comparisons test for panels O-R. ** p < 0.01, *** p < 0.001, **** p < 0.0001.

Journal: Gut Microbes

Article Title: Lactylated MOESIN links gut metabolism to TGF-β–driven immune remodeling and bone protection in diabetic osteoporosis

doi: 10.1080/19490976.2026.2757330

Figure Lengend Snippet: FMT improves DOP in mice by regulating the TGF- β signaling pathway through L-MOESIN. Note: (A-G) Micro-CT analysis of BMD and trabecular architecture across the Control, DOP, DOP+ L. agilis , DOP+FMT, DOP+FMT+L-MOESIN Ab, and DOP+FMT− L. agilis groups; L. agilis denotes the donor-derived ASV_4100-matched Ligilactobacillus agilis isolate, and DOP+FMT− L. agilis denotes strain-matched phage-mediated depletion of L. agilis . Scale bar = 1 mm; (H-J) serum analysis of inflammatory cytokines (CRP, IL-6, TNF-alpha); (K) H&E staining of distal femoral cancellous bone (scale bar = 50 μm); (L) Masson staining (scale bar = 50 μm); (M) TRAP staining (scale bar = 50 μm); (N) Western blot analysis of OCN, Runx2, Cathepsin K, and RANK; (O-R) densitometric quantification. Data are presented as mean ± SD, n = 6 mice per group. Statistical analysis was performed using ANOVA followed by Šídák's multiple-comparisons test for panels B-J and Tukey's multiple-comparisons test for panels O-R. ** p < 0.01, *** p < 0.001, **** p < 0.0001.

Article Snippet: ELISA determined serum levels of CRP, IL-6, and TNF- α . CRP was measured using the Mouse CRP ELISA Kit (ab222511, Abcam, UK); IL-6 using the Mouse IL-6 Quantikine ELISA Kit (M6000B, R&D Systems, USA); and TNF- α using the Mouse TNF-alpha ELISA Kit (ab208348, Abcam, UK).

Techniques: Micro-CT, Analysis, Control, Derivative Assay, Staining, Masson's Trichrome Staining, TRAP Staining, Western Blot